Structure

Physi-Chem Properties

Molecular Weight:  2144.93
Volume:  1996.506
LogP:  0.709
LogD:  0.499
LogS:  -2.076
# Rotatable Bonds:  31
TPSA:  783.41
# H-Bond Aceptor:  51
# H-Bond Donor:  27
# Rings:  16
# Heavy Atoms:  51

MedChem Properties

QED Drug-Likeness Score:  0.015
Synthetic Accessibility Score:  8.682
Fsp3:  0.878
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.603
MDCK Permeability:  0.002833159174770117
Pgp-inhibitor:  0.0
Pgp-substrate:  1.0
Human Intestinal Absorption (HIA):  1.0
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.306
Plasma Protein Binding (PPB):  52.24867248535156%
Volume Distribution (VD):  -1.161
Pgp-substrate:  20.68317222595215%

ADMET: Metabolism

CYP1A2-inhibitor:  0.0
CYP1A2-substrate:  0.014
CYP2C19-inhibitor:  0.0
CYP2C19-substrate:  0.041
CYP2C9-inhibitor:  0.0
CYP2C9-substrate:  0.0
CYP2D6-inhibitor:  0.0
CYP2D6-substrate:  0.011
CYP3A4-inhibitor:  0.014
CYP3A4-substrate:  0.0

ADMET: Excretion

Clearance (CL):  -2.807
Half-life (T1/2):  0.7

ADMET: Toxicity

hERG Blockers:  0.208
Human Hepatotoxicity (H-HT):  0.05
Drug-inuced Liver Injury (DILI):  0.032
AMES Toxicity:  0.032
Rat Oral Acute Toxicity:  0.05
Maximum Recommended Daily Dose:  0.0
Skin Sensitization:  0.613
Carcinogencity:  0.005
Eye Corrosion:  0.003
Eye Irritation:  0.006
Respiratory Toxicity:  0.019

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC135334

Natural Product ID:  NPC135334
Common Name*:   Clematernoside E
IUPAC Name:   [(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(2S,3R,4S,5S)-3-[(2S,3R,4R,5S,6S)-4-[(2S,3R,4S,5R)-5-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-5-[(2S,3R,4S,5R,6R)-5-hydroxy-3-[(E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyl]oxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-3,5-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
Synonyms:   Clematernoside E
Standard InCHIKey:  LYZNTGCVMWIGPU-YWLSKINTSA-N
Standard InCHI:  InChI=1S/C98H152O51/c1-35-54(105)62(113)69(120)82(133-35)130-32-47-58(109)64(115)71(122)87(140-47)147-79-61(112)44(28-99)136-91(81(79)143-53(104)17-13-38-12-15-43(128-11)41(102)26-38)145-77-46(30-101)138-86(74(125)67(77)118)139-49-34-132-84(68(119)60(49)111)146-78-56(107)37(3)135-89(75(78)126)148-80-57(108)42(103)31-129-90(80)142-52-19-20-95(8)50(94(52,6)7)18-21-97(10)51(95)16-14-39-40-27-93(4,5)22-24-98(40,25-23-96(39,97)9)92(127)149-88-72(123)65(116)59(110)48(141-88)33-131-83-73(124)66(117)76(45(29-100)137-83)144-85-70(121)63(114)55(106)36(2)134-85/h12-15,17,26,35-37,40,42,44-52,54-91,99-103,105-126H,16,18-25,27-34H2,1-11H3/b17-13+/t35-,36-,37-,40-,42-,44+,45+,46+,47+,48+,49+,50-,51+,52-,54-,55-,56-,57-,58+,59+,60+,61+,62+,63+,64-,65-,66+,67+,68+,69+,70+,71+,72+,73+,74+,75+,76+,77+,78+,79-,80+,81+,82+,83+,84-,85-,86-,87-,88-,89-,90-,91-,95-,96+,97+,98-/m0/s1
SMILES:  OC[C@H]1O[C@@H](O[C@@H]2CO[C@H]([C@@H]([C@@H]2O)O)O[C@H]2[C@@H](O)[C@H](O[C@H]3[C@@H](OC[C@@H]([C@@H]3O)O)O[C@H]3CC[C@]4([C@H](C3(C)C)CC[C@@]3([C@@H]4CC=C4[C@@]3(C)CC[C@@]3([C@H]4CC(C)(C)CC3)C(=O)O[C@@H]3O[C@H](CO[C@@H]4O[C@H](CO)[C@H]([C@@H]([C@H]4O)O)O[C@@H]4O[C@@H](C)[C@@H]([C@H]([C@H]4O)O)O)[C@H]([C@@H]([C@H]3O)O)O)C)C)O[C@H]([C@@H]2O)C)[C@@H]([C@H]([C@@H]1O[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1OC(=O)/C=C/c1ccc(c(c1)O)OC)O[C@@H]1O[C@H](CO[C@@H]2O[C@@H](C)[C@@H]([C@H]([C@H]2O)O)O)[C@H]([C@@H]([C@H]1O)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1171446
PubChem CID:   49799266
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0001580] Triterpene glycosides
            • [CHEMONTID:0002358] Triterpene saponins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6583 Clematis chinensis Species Ranunculaceae Eukaryota roots n.a. n.a. PMID[15387651]
NPO6583 Clematis chinensis Species Ranunculaceae Eukaryota roots and rhizomes Shaoguan, Guangdong Province, China 2007-Dec PMID[20540535]
NPO6583 Clematis chinensis Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO6583 Clematis chinensis Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO6583 Clematis chinensis Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO6583 Clematis chinensis Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO6583 Clematis chinensis Species Ranunculaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT30 Individual Protein Cyclooxygenase-1 Homo sapiens IC50 = 8300.0 nM PMID[534771]
NPT31 Individual Protein Cyclooxygenase-2 Homo sapiens IC50 = 8500.0 nM PMID[534771]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC135334 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC469776
1.0 High Similarity NPC469775
1.0 High Similarity NPC469773
1.0 High Similarity NPC469778
1.0 High Similarity NPC469772
1.0 High Similarity NPC469777
1.0 High Similarity NPC32723
1.0 High Similarity NPC469774
1.0 High Similarity NPC100925
1.0 High Similarity NPC295941
0.9 High Similarity NPC473773
0.9 High Similarity NPC475579
0.8957 High Similarity NPC471878
0.8938 High Similarity NPC118033
0.8929 High Similarity NPC471870
0.8916 High Similarity NPC25889
0.8882 High Similarity NPC124828
0.887 High Similarity NPC475299
0.883 High Similarity NPC473630
0.882 High Similarity NPC475311
0.882 High Similarity NPC473579
0.882 High Similarity NPC473680
0.882 High Similarity NPC475454
0.8772 High Similarity NPC471871
0.8758 High Similarity NPC470927
0.8758 High Similarity NPC257970
0.8757 High Similarity NPC286809
0.8743 High Similarity NPC246024
0.8743 High Similarity NPC471873
0.8713 High Similarity NPC13989
0.8712 High Similarity NPC471874
0.8701 High Similarity NPC476067
0.8701 High Similarity NPC475121
0.8696 High Similarity NPC473427
0.8696 High Similarity NPC471062
0.8696 High Similarity NPC306890
0.8696 High Similarity NPC259347
0.8696 High Similarity NPC476398
0.8696 High Similarity NPC470933
0.8696 High Similarity NPC94871
0.8696 High Similarity NPC476386
0.869 High Similarity NPC100420
0.8683 High Similarity NPC471869
0.8671 High Similarity NPC469397
0.8655 High Similarity NPC472803
0.8655 High Similarity NPC179240
0.8644 High Similarity NPC189704
0.8606 High Similarity NPC131532
0.8598 High Similarity NPC205392
0.8598 High Similarity NPC105942
0.8596 High Similarity NPC266545
0.8596 High Similarity NPC202428
0.8588 High Similarity NPC96194
0.8588 High Similarity NPC299855
0.8588 High Similarity NPC200726
0.858 High Similarity NPC473205
0.858 High Similarity NPC473776
0.8571 High Similarity NPC232992
0.8562 High Similarity NPC307205
0.8555 High Similarity NPC475197
0.8555 High Similarity NPC473467
0.8538 High Similarity NPC185498
0.8538 High Similarity NPC177362
0.8537 High Similarity NPC478268
0.8528 High Similarity NPC470619
0.8528 High Similarity NPC145527
0.8528 High Similarity NPC470618
0.8528 High Similarity NPC208785
0.8523 High Similarity NPC188217
0.8506 High Similarity NPC469354
0.848 Intermediate Similarity NPC306475
0.8466 Intermediate Similarity NPC478242
0.8462 Intermediate Similarity NPC7191
0.8462 Intermediate Similarity NPC149873
0.8457 Intermediate Similarity NPC475054
0.8453 Intermediate Similarity NPC473711
0.8452 Intermediate Similarity NPC478269
0.8448 Intermediate Similarity NPC316539
0.8447 Intermediate Similarity NPC53520
0.8447 Intermediate Similarity NPC34927
0.8447 Intermediate Similarity NPC252292
0.8447 Intermediate Similarity NPC34587
0.8447 Intermediate Similarity NPC100998
0.8447 Intermediate Similarity NPC476382
0.8438 Intermediate Similarity NPC469447
0.8438 Intermediate Similarity NPC477873
0.8424 Intermediate Similarity NPC106818
0.8415 Intermediate Similarity NPC470934
0.8415 Intermediate Similarity NPC12006
0.8415 Intermediate Similarity NPC188393
0.8407 Intermediate Similarity NPC476358
0.84 Intermediate Similarity NPC469438
0.8398 Intermediate Similarity NPC112708
0.8395 Intermediate Similarity NPC320734
0.8385 Intermediate Similarity NPC264270
0.8385 Intermediate Similarity NPC64195
0.8385 Intermediate Similarity NPC40085
0.8373 Intermediate Similarity NPC106669
0.8373 Intermediate Similarity NPC299706
0.8373 Intermediate Similarity NPC115466
0.8373 Intermediate Similarity NPC475227
0.8373 Intermediate Similarity NPC200645
0.8373 Intermediate Similarity NPC61604
0.8373 Intermediate Similarity NPC87403
0.8373 Intermediate Similarity NPC245615
0.8364 Intermediate Similarity NPC7145
0.8364 Intermediate Similarity NPC143480
0.8364 Intermediate Similarity NPC85192
0.8364 Intermediate Similarity NPC125823
0.8363 Intermediate Similarity NPC116759
0.8363 Intermediate Similarity NPC227297
0.8363 Intermediate Similarity NPC14294
0.8353 Intermediate Similarity NPC266365
0.8353 Intermediate Similarity NPC478267
0.8352 Intermediate Similarity NPC475613
0.8352 Intermediate Similarity NPC472723
0.8343 Intermediate Similarity NPC179914
0.8343 Intermediate Similarity NPC230670
0.8343 Intermediate Similarity NPC71385
0.8333 Intermediate Similarity NPC272619
0.8333 Intermediate Similarity NPC228357
0.8333 Intermediate Similarity NPC43434
0.8333 Intermediate Similarity NPC52598
0.8333 Intermediate Similarity NPC286245
0.8333 Intermediate Similarity NPC472129
0.8333 Intermediate Similarity NPC11411
0.8323 Intermediate Similarity NPC476397
0.8323 Intermediate Similarity NPC96795
0.8323 Intermediate Similarity NPC278961
0.8323 Intermediate Similarity NPC205864
0.8323 Intermediate Similarity NPC476381
0.8323 Intermediate Similarity NPC247032
0.8323 Intermediate Similarity NPC476375
0.8323 Intermediate Similarity NPC476384
0.8323 Intermediate Similarity NPC476380
0.8323 Intermediate Similarity NPC264632
0.8323 Intermediate Similarity NPC204644
0.8323 Intermediate Similarity NPC476378
0.8323 Intermediate Similarity NPC175214
0.8323 Intermediate Similarity NPC298257
0.8323 Intermediate Similarity NPC111466
0.8323 Intermediate Similarity NPC119537
0.8323 Intermediate Similarity NPC112
0.8323 Intermediate Similarity NPC269141
0.8323 Intermediate Similarity NPC76406
0.8323 Intermediate Similarity NPC113680
0.8313 Intermediate Similarity NPC304110
0.8313 Intermediate Similarity NPC27518
0.8304 Intermediate Similarity NPC140346
0.8304 Intermediate Similarity NPC12326
0.8303 Intermediate Similarity NPC476871
0.8295 Intermediate Similarity NPC475244
0.8293 Intermediate Similarity NPC3460
0.8293 Intermediate Similarity NPC300262
0.8293 Intermediate Similarity NPC192763
0.8293 Intermediate Similarity NPC28651
0.8293 Intermediate Similarity NPC201148
0.8293 Intermediate Similarity NPC210611
0.8293 Intermediate Similarity NPC261122
0.8293 Intermediate Similarity NPC23677
0.8293 Intermediate Similarity NPC199311
0.8293 Intermediate Similarity NPC116229
0.8293 Intermediate Similarity NPC80732
0.8293 Intermediate Similarity NPC215095
0.8286 Intermediate Similarity NPC148185
0.8286 Intermediate Similarity NPC477617
0.8282 Intermediate Similarity NPC476865
0.8276 Intermediate Similarity NPC658
0.8276 Intermediate Similarity NPC472133
0.8276 Intermediate Similarity NPC197708
0.8276 Intermediate Similarity NPC21956
0.8274 Intermediate Similarity NPC38699
0.8272 Intermediate Similarity NPC471065
0.8272 Intermediate Similarity NPC253015
0.8272 Intermediate Similarity NPC25491
0.8268 Intermediate Similarity NPC476203
0.8266 Intermediate Similarity NPC59516
0.8261 Intermediate Similarity NPC222433
0.8261 Intermediate Similarity NPC140502
0.8261 Intermediate Similarity NPC265648
0.8258 Intermediate Similarity NPC161609
0.8258 Intermediate Similarity NPC275690
0.8256 Intermediate Similarity NPC121290
0.825 Intermediate Similarity NPC155192
0.825 Intermediate Similarity NPC271494
0.825 Intermediate Similarity NPC473591
0.8249 Intermediate Similarity NPC66820
0.8249 Intermediate Similarity NPC67629
0.8249 Intermediate Similarity NPC79736
0.8249 Intermediate Similarity NPC92403
0.8249 Intermediate Similarity NPC76112
0.8249 Intermediate Similarity NPC170018
0.8246 Intermediate Similarity NPC100465
0.8246 Intermediate Similarity NPC152424
0.8242 Intermediate Similarity NPC44452
0.8235 Intermediate Similarity NPC469384
0.8232 Intermediate Similarity NPC470330
0.8225 Intermediate Similarity NPC163635
0.8222 Intermediate Similarity NPC318119
0.8221 Intermediate Similarity NPC476869

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC135334 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8538 High Similarity NPD7228 Approved
0.8261 Intermediate Similarity NPD8166 Discontinued
0.8249 Intermediate Similarity NPD8313 Approved
0.8249 Intermediate Similarity NPD8312 Approved
0.8156 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.814 Intermediate Similarity NPD8127 Discontinued
0.8136 Intermediate Similarity NPD7240 Approved
0.8129 Intermediate Similarity NPD6234 Discontinued
0.8122 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8107 Intermediate Similarity NPD8455 Phase 2
0.8075 Intermediate Similarity NPD7266 Discontinued
0.8047 Intermediate Similarity NPD37 Approved
0.8023 Intermediate Similarity NPD7074 Phase 3
0.8012 Intermediate Similarity NPD4967 Phase 2
0.8012 Intermediate Similarity NPD4965 Approved
0.8012 Intermediate Similarity NPD4966 Approved
0.7933 Intermediate Similarity NPD7685 Pre-registration
0.7921 Intermediate Similarity NPD7472 Approved
0.7865 Intermediate Similarity NPD7054 Approved
0.779 Intermediate Similarity NPD7808 Phase 3
0.7765 Intermediate Similarity NPD7458 Discontinued
0.7742 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7735 Intermediate Similarity NPD7251 Discontinued
0.7708 Intermediate Similarity NPD7680 Approved
0.7684 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.768 Intermediate Similarity NPD6797 Phase 2
0.768 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD6674 Discontinued
0.7602 Intermediate Similarity NPD1653 Approved
0.76 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7569 Intermediate Similarity NPD5844 Phase 1
0.7528 Intermediate Similarity NPD7199 Phase 2
0.7514 Intermediate Similarity NPD3818 Discontinued
0.7513 Intermediate Similarity NPD8151 Discontinued
0.75 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6166 Phase 2
0.75 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD7028 Phase 2
0.7396 Intermediate Similarity NPD4628 Phase 3
0.7396 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD7473 Discontinued
0.736 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD6190 Approved
0.7351 Intermediate Similarity NPD6559 Discontinued
0.7349 Intermediate Similarity NPD7097 Phase 1
0.7348 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD7003 Approved
0.7293 Intermediate Similarity NPD6232 Discontinued
0.7288 Intermediate Similarity NPD1465 Phase 2
0.7283 Intermediate Similarity NPD6273 Approved
0.7264 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7264 Intermediate Similarity NPD7783 Phase 2
0.7259 Intermediate Similarity NPD7435 Discontinued
0.7249 Intermediate Similarity NPD8434 Phase 2
0.7241 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD1934 Approved
0.7225 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD8319 Approved
0.7222 Intermediate Similarity NPD8320 Phase 1
0.7193 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD4110 Phase 3
0.7191 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD7697 Approved
0.7172 Intermediate Similarity NPD7696 Phase 3
0.7172 Intermediate Similarity NPD7698 Approved
0.7169 Intermediate Similarity NPD3620 Phase 2
0.7169 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD8150 Discontinued
0.7136 Intermediate Similarity NPD7871 Phase 2
0.7136 Intermediate Similarity NPD7870 Phase 2
0.7135 Intermediate Similarity NPD3751 Discontinued
0.7129 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7129 Intermediate Similarity NPD7874 Approved
0.7121 Intermediate Similarity NPD6823 Phase 2
0.7119 Intermediate Similarity NPD4380 Phase 2
0.7114 Intermediate Similarity NPD7701 Phase 2
0.7107 Intermediate Similarity NPD6776 Approved
0.7107 Intermediate Similarity NPD6782 Approved
0.7107 Intermediate Similarity NPD6780 Approved
0.7107 Intermediate Similarity NPD6777 Approved
0.7107 Intermediate Similarity NPD6781 Approved
0.7107 Intermediate Similarity NPD6779 Approved
0.7107 Intermediate Similarity NPD6778 Approved
0.7097 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD7819 Suspended
0.7091 Intermediate Similarity NPD3027 Phase 3
0.7072 Intermediate Similarity NPD7075 Discontinued
0.7062 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD6959 Discontinued
0.7048 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7017 Intermediate Similarity NPD7768 Phase 2
0.7011 Intermediate Similarity NPD3787 Discontinued
0.701 Intermediate Similarity NPD7801 Approved
0.7005 Intermediate Similarity NPD7699 Phase 2
0.7005 Intermediate Similarity NPD7700 Phase 2
0.6995 Remote Similarity NPD5494 Approved
0.6964 Remote Similarity NPD1613 Approved
0.6964 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6961 Remote Similarity NPD3817 Phase 2
0.6961 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6952 Remote Similarity NPD7799 Discontinued
0.6935 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6933 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6355 Discontinued
0.6906 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6906 Remote Similarity NPD2801 Approved
0.6905 Remote Similarity NPD8032 Phase 2
0.6905 Remote Similarity NPD6663 Approved
0.6897 Remote Similarity NPD3750 Approved
0.6886 Remote Similarity NPD7095 Approved
0.6872 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6867 Remote Similarity NPD5736 Approved
0.6864 Remote Similarity NPD4060 Phase 1
0.6864 Remote Similarity NPD4140 Approved
0.686 Remote Similarity NPD6099 Approved
0.686 Remote Similarity NPD6100 Approved
0.686 Remote Similarity NPD2935 Discontinued
0.686 Remote Similarity NPD2438 Suspended
0.6853 Remote Similarity NPD6534 Approved
0.6853 Remote Similarity NPD6535 Approved
0.6845 Remote Similarity NPD6798 Discontinued
0.6839 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6836 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6836 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6832 Remote Similarity NPD7497 Discontinued
0.6831 Remote Similarity NPD3882 Suspended
0.6824 Remote Similarity NPD230 Phase 1
0.6823 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6821 Remote Similarity NPD5762 Approved
0.6821 Remote Similarity NPD5763 Approved
0.681 Remote Similarity NPD3705 Approved
0.6805 Remote Similarity NPD6233 Phase 2
0.6796 Remote Similarity NPD7411 Suspended
0.6778 Remote Similarity NPD3226 Approved
0.6776 Remote Similarity NPD5402 Approved
0.6758 Remote Similarity NPD6801 Discontinued
0.6746 Remote Similarity NPD6410 Clinical (unspecified phase)
0.674 Remote Similarity NPD6599 Discontinued
0.6736 Remote Similarity NPD7313 Approved
0.6736 Remote Similarity NPD7310 Approved
0.6736 Remote Similarity NPD7311 Approved
0.6736 Remote Similarity NPD7312 Approved
0.6728 Remote Similarity NPD1357 Approved
0.6726 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6725 Remote Similarity NPD5735 Approved
0.6725 Remote Similarity NPD1933 Approved
0.6719 Remote Similarity NPD8368 Discontinued
0.6719 Remote Similarity NPD7038 Approved
0.6719 Remote Similarity NPD7039 Approved
0.6717 Remote Similarity NPD6212 Phase 3
0.6717 Remote Similarity NPD6213 Phase 3
0.6717 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6707 Remote Similarity NPD1091 Approved
0.6703 Remote Similarity NPD6677 Suspended
0.6701 Remote Similarity NPD2488 Approved
0.6701 Remote Similarity NPD2490 Approved
0.6701 Remote Similarity NPD7309 Approved
0.6687 Remote Similarity NPD8651 Approved
0.6687 Remote Similarity NPD1283 Approved
0.6686 Remote Similarity NPD6653 Approved
0.6686 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6686 Remote Similarity NPD970 Clinical (unspecified phase)
0.6685 Remote Similarity NPD1511 Approved
0.6684 Remote Similarity NPD7906 Approved
0.6684 Remote Similarity NPD7549 Discontinued
0.6683 Remote Similarity NPD7999 Approved
0.6667 Remote Similarity NPD27 Approved
0.6667 Remote Similarity NPD5403 Approved
0.6667 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2489 Approved
0.6667 Remote Similarity NPD9494 Approved
0.6667 Remote Similarity NPD2979 Phase 3
0.6667 Remote Similarity NPD7930 Approved
0.665 Remote Similarity NPD2493 Approved
0.665 Remote Similarity NPD2494 Approved
0.6648 Remote Similarity NPD2534 Approved
0.6648 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6648 Remote Similarity NPD2532 Approved
0.6648 Remote Similarity NPD2533 Approved
0.6647 Remote Similarity NPD2797 Approved
0.6647 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6647 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6647 Remote Similarity NPD3764 Approved
0.6634 Remote Similarity NPD4583 Approved
0.6634 Remote Similarity NPD4582 Approved
0.6629 Remote Similarity NPD2346 Discontinued
0.6629 Remote Similarity NPD7236 Approved
0.6629 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6629 Remote Similarity NPD6005 Phase 3
0.6629 Remote Similarity NPD6004 Phase 3
0.6629 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6629 Remote Similarity NPD6002 Phase 3
0.6628 Remote Similarity NPD5124 Phase 1
0.6628 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6628 Remote Similarity NPD447 Suspended
0.6627 Remote Similarity NPD4908 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data